Literature DB >> 14605940

Performance of BACTEC 960 Mycobacteria growth indicator tube in the susceptibility testing of genetically characterized Mycobacterium tuberculosis isolates.

H J Marttila1, M Marjamäki, M K Viljanen, H Soini.   

Abstract

In this study, the 7H10 agar proportion method was compared with the BACTEC TB-460 and BACTEC MGIT 960 systems (BD Biosciences, USA) for the susceptibility testing of 22 genetically characterized Mycobacterium tuberculosis isolates for isoniazid, rifampin, streptomycin, and ethambutol. The 7H10 agar proportion method agreed with the resistant genotype in 87.3%, BACTEC TB-460 in 92.7%, and the MGIT in 96.4% of the cases, showing the high sensitivity of MGIT in the detection of resistant isolates.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14605940     DOI： 10.1007/s10096-003-1030-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  14 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Reliability of mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to ethambutol and streptomycin.

Authors:  J S Bergmann; G L Woods
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

3.  Mycobacterial growth indicator tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.

Authors:  J S Bergmann; G L Woods
Journal:  Diagn Microbiol Infect Dis       Date:  1997-07       Impact factor: 2.803

4.  Preparation of tuberculosis susceptibility testing mediums by means of impregnated disks.

Authors:  L G Wayne; I Krasnow
Journal:  Am J Clin Pathol       Date:  1966-06       Impact factor: 2.493

5.  Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  F Ardito; B Posteraro; M Sanguinetti; S Zanetti; G Fadda
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

6.  Mutations in the embB locus among Korean clinical isolates of Mycobacterium tuberculosis resistant to ethambutol.

Authors:  Hye Young Lee; Han Jung Myoung; Hye Eun Bang; Gill-Han Bai; Sang-Jae Kim; Joo Deuk Kim; Sang-Nae Cho
Journal:  Yonsei Med J       Date:  2002-02       Impact factor: 2.759

7.  Rapid susceptibility testing of Mycobacterium tuberculosis by the Mycobacteria Growth Indicator Tube (MGIT AST SIRE).

Authors:  E A Macondo; F Ba; A Gaye-Diallo; N C Touré-Kane; O Kaïré; A Gueye-Ndiaye; C S Boye; S Mboup
Journal:  Clin Microbiol Infect       Date:  2000-07       Impact factor: 8.067

8.  Evaluation of mycobacteria growth indicator tubes for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.

Authors:  B S Reisner; A M Gatson; G L Woods
Journal:  Diagn Microbiol Infect Dis       Date:  1995-08       Impact factor: 2.803

9.  Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs.

Authors:  S Rüsch-Gerdes; C Domehl; G Nardi; M R Gismondo; H M Welscher; G E Pfyffer
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

10.  Testing of susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by mycobacterium growth indicator tube method.

Authors:  S B Walters; B A Hanna
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948
View more
  1 in total

Review 1.  Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems.

Authors:  Claudio Piersimoni; Armando Olivieri; Luca Benacchio; Claudio Scarparo
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.